## PG: Procter & Gamble Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -4.6% below STRENGTH zone (3.0-6.0%); PEG 4.21 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Federated Hermes Inc. Sells 11,292 Shares of Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251208T094717 | Somewhat-Bullish | Relevance: 99%
-  Federated Hermes Inc. reduced its stake in Procter & Gamble (NYSE:PG) by 2.4% during Q2, selling 11,292 shares and now holding 450,347 shares valued at approximately $71.75 million. Meanwhile, insider sales were noted from COO Shailesh Jejurikar and CFO Andre Schulten. The stock is currently trading near its 52-week low but has an average analyst target price of $171.53, indicating a "Moderate Buy" consensus.

**2. P&G (PG) Stock: 8 Things to Know Before the Market Opens on December 8, 2025**
- Source: ts2.tech | 20251207T210909 | Neutral | Relevance: 99%
- Procter & Gamble (NYSE: PG) stock is trading near two-year lows, driven by cautious consumer spending and upcoming restructuring and CEO transition. Despite a mixed institutional positioning and ongoing debate on valuation, Wall Street analysts maintain a "Moderate Buy" consensus with double-digit upside potential. The company's exceptional dividend track record continues to attract income investors, though its total returns have lagged broader market indexes.

**3. PG Stock Price Near 2‑Year Low as P&G Warns on U.S. Sales: Outlook, Forecasts and Dividend Update**
- Source: ts2.tech | 20251207T220850 | Neutral | Relevance: 98%
- Procter & Gamble (NYSE: PG) stock is trading near a two-year low despite strong earnings and a long history of dividend growth, largely due to warnings about weaker U.S. sales, a 7,000-job restructuring, and an upcoming CEO transition. While analysts broadly recommend a "Buy" with an average 12-month target implying 16-22% upside, valuation opinions vary, and technical indicators suggest weak momentum. The company maintains its full-year guidance, anticipating a recovery in U.S. demand later in the fiscal year, and continues to offer a robust dividend yield of approximately 3% for income-focused investors.

**4. Electric Shavers Global Market Intelligence: Shares, Trends and Prospects 2025-2030 Featuring Conair, Philips, Panasonic, Procter & Gamble, Spectrum Brands and More - ResearchAndMarkets.com**
- Source: Markets Financial Content | 20251209T121300 | Somewhat-Bullish | Relevance: 98%
- The global electric shavers market is projected to reach USD 15.802 billion by 2030, growing at a CAGR of 6.06% from USD 11.773 billion in 2025. This growth is driven by increasing beauty consciousness and rising disposable incomes, particularly in emerging economies like China and India, despite challenges from traditional razors and high costs. Key players like Philips and Panasonic are focusing on innovation and e-commerce to capitalize on market opportunities.

**5. California Public Employees Retirement System Reduces Stock Holdings in Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251207T090842 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System (CalPERS) reduced its stake in Procter & Gamble (NYSE:PG) by 15.7% in Q2, selling approximately 1.28 million shares and now holding 6.87 million shares valued at about $1.094 billion. This reduction makes Procter & Gamble the 18th largest position in CalPERS' holdings, representing 0.7% of its total portfolio. Insider selling also occurred, with CEO Gary A. Coombe and COO Shailesh Jejurikar selling shares in early October, while several other institutional investors either increased or initiated positions in the company.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 46 ($0.05M) |
| Sells | 17 ($4.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.6%)
- Blackrock Inc.: 7.6% (+3.8%)
- State Street Corpora: 4.3% (+0.4%)
- Geode Capital Manage: 2.6% (+2.1%)
- Morgan Stanley: 2.2% (-1.3%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.7% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.9M in recent transactions.
3. Valuation stretched: PEG 4.2x requires aggressive growth execution.
4. Long-term trend broken: trading 11.8% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.21 signals overvaluation risk, limited margin of safety. Forward P/E 18.9x stretched relative to 5% growth. Quality metrics strong (ROE 32%, ROA 11%, margin 20%). Balance sheet: $4.2B free cash flow. Insider selling cluster ($4.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $326.8B |
| Beta | 0.38 |
| 52W Range | $138.14 - $179.99 |
| Short Interest | 0.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.21 |
| Forward P/E | 18.9 |
| Current P/E | 19.9 |
| YoY Growth | 5.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -2.9% to -4.6% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.6pp (needs >3.0% for momentum thesis). Below SMA200 (0.88x), long-term trend not supportive. MACD histogram bearish (-0.79), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.57% (CS: 9) | Weak |
| RSI_14 | 32.3 | Neutral |
| MACD Histogram | -0.79 | Bearish |
| vs SMA20 | 0.953x | Below |
| vs SMA50 | 0.939x | Below |
| vs SMA200 | 0.882x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.63
- **Stop Loss:** $134.29 (3.8% risk)
- **Target:** $144.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $12,985.59
- **Portfolio %:** 12.99%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-22 (Est: $1.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.90 | $1.99 | +4.9% |
| 2025Q2 | $1.42 | $1.48 | +4.1% |
| 2025Q1 | $1.53 | $1.54 | +0.9% |
| 2024Q4 | $1.86 | $1.88 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*